InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Net Income (2016 - 2026)

InflaRx's (IFRX) quarterly Net Income came in at -$12.4 million in Q2 2026, up 24.15% year-over-year from -$10.0 million in Q2 2025, and down 89.04% quarter-over-quarter from -$6.5 million in Q1 2026.

Analysis

InflaRx (IFRX) Net Income (2016 - 2026) Analysis & Trends

InflaRx has disclosed Net Income across 11 years of filings, most recently posting -$12.4 million for Q2 2026.

  • In Q2 2026, Net Income rose 24.15% year-over-year to -$12.4 million; the TTM figure through Jun 2026 stood at $60.6 million (up 2215.33% YoY), while the FY2025 annual figure was $51.6 million, up 4.74% from the prior year.
  • Net Income came in at -$12.4 million for Q2 2026 at InflaRx, down from -$6.5 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $93.9 million in Q4 2025 to a low of -$70.8 million in Q3 2024.
  • Average Net Income over 5 years is $8.8 million, with a median of -$9.6 million recorded in 2024.
  • Year-over-year, Net Income surged 458.62% in 2022 and slumped 145.7% in 2025.
  • Over 5 years, Net Income stood at $52.0 million in 2022, then jumped by 43.68% to $74.7 million in 2023, then gained by 24.52% to $93.0 million in 2024, then rose by 0.93% to $93.9 million in 2025, then tumbled by 113.19% to -$12.4 million in 2026.
  • Per Business Quant data, the three most recent Net Income figures were -$12.4 million in Q2 2026, -$6.5 million in Q1 2026, and $93.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 601.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -290.61 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn -12.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.38 Mn
Mar 31, 2026 -6.55 Mn
Dec 31, 2025 93.85 Mn
Sep 30, 2025 -14.33 Mn
Jun 30, 2025 -16.32 Mn
Mar 31, 2025 -8.75 Mn
Dec 31, 2024 92.99 Mn
Sep 30, 2024 -70.79 Mn
Jun 30, 2024 35.71 Mn
Mar 31, 2024 -10.49 Mn
Dec 31, 2023 74.68 Mn
Sep 30, 2023 -50.10 Mn
Jun 30, 2023 33.07 Mn
Mar 31, 2023 -11.90 Mn
Dec 31, 2022 51.97 Mn
Sep 30, 2022 -35.28 Mn
Jun 30, 2022 29.39 Mn
Mar 31, 2022 -15.72 Mn
Dec 31, 2021 -14.49 Mn
Sep 30, 2021 -63.53 Mn